Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability.  Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

1 Oct 2018 07:00

RNS Number : 0401C
Standard Life Private Eqty Trst PLC
01 October 2018
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2018

 

· The net asset value ("NAV") per ordinary share of Standard Life Private Equity Trust PLC ("the Company") increased by 6.9% to 417.3 pence for the quarter ended 30 June 2018

· Realised gains and income during the quarter ended 30 June 2018 totalled £26.9 million (4.5% of NAV). The unrealised gains on a constant exchange rate basis were £12.0 million (2.0% of NAV). In addition, there were unrealised foreign exchange gains of £6.5 million (1.1% of NAV)

· The first quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share was paid on 27 April 2018

· 98.4% by value of the portfolio was valued by the respective underlying managers at 30 June 2018

· NAV total return was 9.2% for the nine months from 1 October 2017 to 30 June 2018

· Outstanding commitments were £397.2 million at 30 June 2018

· Liquid resources were £99.3 million at 30 June 2018

 

For the quarter ended 30 June 2018, the Company's NAV increased by 6.9% to 417.3 pence per share, from 390.4 pence per share at 31 March 2018. At 30 June 2018, the Company's net assets were £641.6 million (31 March 2018 - £600.2 million). NAV total return was 9.2% for the nine months from 1 October 2017 to 30 June 2018.

 

The closing value of the Company's unquoted portfolio, which, included 56 private equity fund interests, was £541.9 million at 30 June 2018 (31 March 2018 - £518.6 million and 54 private equity fund interests). The total unrealised gains on the unquoted portfolio for the quarter ended 30 June 2018 were £18.5 million, comprising £12.0 million of unrealised gains on a constant exchange rate basis and £6.5 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) rose by 3.3% and 7.9% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro and the US Dollar appreciating by 0.9% and 5.9% respectively, relative to sterling over the quarter.

 

During the quarter ended 30 June 2018, the unquoted portfolio generated £32.5 million of distributions (six months ended 31 March 2018 - £75.5 million). The Company funded £10.4 million of drawdowns (six months ended 31 March 2018 - £51.1 million) into the unquoted portfolio. The distributions received during the quarter generated £26.9 million of net realised gains and income, which was equivalent to a return of 5.8 times the acquisition cost of the realised investments.

 

The Company paid the first quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share on 27 April 2018. The cash cost of the dividend was £4.8 million.

 

The Company made two new fund commitments of €25.0 million and $21.5 million to Investindustrial Growth and MSouth Equity Partners IV respectively. The Company had total outstanding commitments to its 56 private equity fund interests of £397.2 million at 30 June 2018 (31 March 2018 - £360.0 million to 54 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2018, the Company had liquid resources of £99.3 million (31 March 2018 - liquid resources of £81.3 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

2. Activity since 30 June 2018

 

On 27 July 2018, the Company paid the second quarter dividend for the year ending 30 September 2018 of 3.1 pence per ordinary share. The cost of the final dividend was £4.8 million. In addition, the Company declared a third quarter dividend for the year ending 30 September 2018 of 3.1 pence per ordinary share, to be paid on 26 October 2018, to shareholders on the Company's share register as at 21 September 2018.

 

During the period from 1 July 2018 to 14 September 2018, the Company funded £20.5 million of drawdowns and received £20.7 million of distributions.

 

At 14 September 2018, the Company had liquid resources of £95.1 million. The Company also had total outstanding commitments of £380.0 million.

 

The Company's estimated NAV at 31 August 2018 is also being announced today. It is anticipated that the Company will release its results for the financial year ending 30 September 2018 on or around 11 December 2018.

 

 

For further information please contact:-

 

Merrick McKay at SL Capital Partners LLP (0131 245 2345)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBXGDCLGDBGIL
Date   Source Headline
7th Dec 20124:53 pmRNSTransaction in Own Shares
3rd Dec 20127:00 amRNSPreliminary Results
1st Oct 201210:48 amRNSQuarterly Disclosure
19th Sep 20127:00 amRNSQuarterly Trading Statement
17th Aug 201210:57 amRNSInterim Management Statement
9th Jul 20125:04 pmRNSHolding(s) in Company
9th Jul 201211:44 amRNSHolding(s) in Company
2nd Jul 20122:39 pmRNSQuarterly Disclosure
1st Jun 20124:56 pmRNSDirector/PDMR Shareholding
29th May 20125:28 pmRNSHalf Yearly Report
24th May 20129:10 amRNSDirector Declaration
2nd Apr 201212:43 pmRNSQuarterly Disclosure
21st Mar 20127:00 amRNSQuarterly Trading Statement
1st Mar 20129:47 amRNSTotal Voting Rights
24th Feb 20129:09 amRNSHolding(s) in Company
22nd Feb 20127:30 amRNSCompany Secretary Change
14th Feb 20122:18 pmRNSDirector/PDMR Shareholding
6th Feb 20124:16 pmRNSDirector/PDMR Shareholding
6th Feb 20124:16 pmRNSDirector/PDMR Shareholding
6th Feb 20124:15 pmRNSDirector/PDMR Shareholding
2nd Feb 20124:45 pmRNSInterim Management Statement
2nd Feb 20124:40 pmRNSSecretary Change
2nd Feb 20124:35 pmRNSResult of AGM
2nd Feb 20124:27 pmRNSDirectorate Change
1st Feb 20129:21 amRNSIssue of Equity
30th Jan 201211:24 amRNSAnnual Financial Report
12th Jan 20124:46 pmRNSAnnual Information Update
11th Jan 20123:32 pmRNSScrip dividend reference price
5th Jan 201210:56 amRNSQuarterly Disclosure
16th Dec 201111:15 amRNSDoc re. Annual Report & Circular
12th Dec 201110:26 amRNSDirector/PDMR Shareholding
7th Dec 20113:42 pmRNSDirector/PDMR Shareholding
5th Dec 20114:19 pmRNSDirector/PDMR Shareholding
5th Dec 20112:20 pmRNSDirector/PDMR Shareholding
5th Dec 20117:00 amRNSPreliminary Results
29th Nov 20113:55 pmRNSHolding(s) in Company
11th Oct 201110:22 amRNSDirector Declaration
5th Oct 20117:00 amRNSManagement Incentive Scheme Arrangements
4th Oct 20114:17 pmRNSQuarterly Disclosure
21st Sep 20117:00 amRNSQuarterly Trading Statement
11th Aug 20117:00 amRNSInterim Management Statement
20th Jul 201110:48 amRNSHolding(s) in Company
4th Jul 20111:08 pmRNSQuarterly Disclosure
15th Jun 201110:31 amRNSDirector/PDMR Shareholding
14th Jun 20113:46 pmRNSDirector/PDMR Shareholding
2nd Jun 20119:26 amRNSReplacement - Half Yearly Report
27th May 20117:00 amRNSHalf Yearly Report
4th Apr 20112:57 pmRNSQuarterly Disclosure
1st Apr 20117:00 amRNSDirectorate Change
21st Mar 20113:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.